Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811030 · ClinicalTrials.gov registry record · NA
Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01811030: Completed NA study, sponsored by Cynosure.
NCT01811030 is a NA study that has completed, run by Cynosure. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01811030, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of removing unwanted scars using a 755nm Alexandrite laser.
Primary Outcome
The échelle d'évaluation clinique des cicatrices d'acné (ECCA) Grading scale was used to evaluate the photographs, using 2D and 3D photography, where the scale ranges from 0 to 4. 0 represents 0% improvement/worse, 1 is 1-25% improvement, 2 is 26-50% improvement, 3 is 51-74% improvement, and 4 is \>75% improvement.
Interventions
- DEVICE 755nm Alexandrite Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-05 |
| Phase | NA |
What the finished NCT01811030 record still lists
NCT01811030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which 755nm Alexandrite Laser is the first listed.
NCT01811030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01811030 about?
NCT01811030 is a clinical study titled "Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars". Evaluate the safety and efficacy of removing unwanted scars using a 755nm Alexandrite laser.
What is the current status of trial NCT01811030?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2012-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01811030?
The interventions under investigation include: 755nm Alexandrite Laser (DEVICE).
Who is sponsoring clinical trial NCT01811030?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01811030's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia